| metastatic/advanced UC (mUC) - 1st Line (L1) | metastatic/advanced UC (mUC) - 2nd Line (L2) | muscular invasive bladder cancer (MIBC) | ||
| mUC - L1 - all population | mUC - L2 - all population | mUC - L2 - PDL1 positive | MIBC - NA - all population | |
| atezolizumab based treatment | ||||
| atezolizumab alone | IMvigor-130 ... | IMvigor-211 ... | IMvigor-211 ... IMvigor-211 ... | IMvigor-010 |
| atezolizumab plus SoC | IMvigor-130 ... | |||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
